IL-7: a potential next-generation adjuvant for immune cell therapies.
Saved in:
| Title: | IL-7: a potential next-generation adjuvant for immune cell therapies. |
|---|---|
| Authors: | Hotchkiss RS; Department of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine, St. Louis, MO, United States., DiPersio JF; Department of Medicine, Washington University School of Medicine, St Louis, MO, United States., Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Pachynski RK; Department of Medicine, Washington University School of Medicine, St Louis, MO, United States., Van Den Brink MRM; City of Hope Los Angeles and National Medical Center, Duarte, CA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jan 02; Vol. 16, pp. 1736931. Date of Electronic Publication: 2026 Jan 02 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1736931 |
